Cell and molecular response to IORT treatment

Translational Cancer Research

Volumn 3, Issue 1, 2014, Pages 32-47

  Minafra, Luigi ^a   Bravatà, Valentina ^a  

^a IBFM CNR LATOIBFM CNR LATO   (Italy)

Author keywords

Cell death; Gene expression profile; Intraoperative radiotherapy (IORT); Ionizing radiations (IRs)

Indexed keywords

EID: 84962755127     PISSN: 2218676X     EISSN: 22196803     Source Type: Journal    
DOI: 10.3978/j.issn.2218-676X.2014.02.03     Document Type: Article

References (145)

1. Hall EJ, Giaccia AJ. eds. Radiobiology for the Radiologist, 6th ed. Philadelphia, PA, USA: Lippincott Williams & Wilkins, 2006:16-180.
2. Zhao W, Diz DI, Robbins ME. Oxidative damage pathways in relation to normal tissue injury. Br J Radiol 2007;80:S23-31.
3. Lomax ME, Folkes LK, O'Neill P. Biological consequences of radiation-induced DNA damage: relevance to radiotherapy. Clin Oncol (R Coll Radiol) 2013;25:578-85.
4. Mladenov E, Magin S, Soni A, et al. DNA double-strand break repair as determinant of cellular radiosensitivity to killing and target in radiation therapy. Front Oncol 2013;3:113.
5. Golden EB, Pellicciotta I, Demaria S, et al. The convergence of radiation and immunogenic cell death signaling pathways. Front Oncol 2012;2:88.
6. Multhoff G, Radons J. Radiation, inflammation, and immune responses in cancer. Front Oncol 2012;2:58.
7. Huang L, Snyder AR, Morgan WF. Radiation-induced genomic instability and its implications for radiation carcinogenesis. Oncogene 2003;22:5848-54.
8. Huang L, Kim PM, Nickoloff JA, et al. Targeted and nontargeted effects of low-dose ionizing radiation on delayed genomic instability in human cells. Cancer Res 2007;67:1099-104.
9. Du J, Gebicki JM. Proteins are major initial cell targets of hydroxyl free radicals. Int J Biochem Cell Biol 2004;36:2334-43.
10. Shuryak I, Brenner DJ. Mechanistic analysis of the contributions of DNA and protein damage to radiation-induced cell death. Radiat Res 2012;178:17-24.
11. Panganiban RA, Mungunsukh O, Day RM. X-irradiation induces ER stress, apoptosis, and senescence in pulmonary artery endothelial cells. Int J Radiat Biol 2013;89:656-67.
12. Tamulevicius P, Wang M, Iliakis G. Homology-directed repair is required for the development of radioresistance during S phase: interplay between double-strand break repair and checkpoint response. Radiat Res 2007;167:1-11.
13. Güerci AM, Dulout FN, Grillo CA, et al. Differential response of two cell lines sequentially irradiated with low X-ray doses. Int J Radiat Biol 2005;81:367-72.
14. Ghardi M, Moreels M, Chatelain B, et al. Radiation-induced double strand breaks and subsequent apoptotic DNA fragmentation in human peripheral blood mononuclear cells. Int J Mol Med 2012;29:769-80.
15. Moeller BJ, Richardson RA, Dewhirst MW. Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment. Cancer Metastasis Rev 2007;26:241-8.
16. Huber SM, Butz L, Stegen B, et al. Ionizing radiation, ion transports, and radioresistance of cancer cells. Front Physiol 2013;4:212.
17. O'Driscoll M, Jeggo PA. The role of double-strand break repair - insights from human genetics. Nat Rev Genet 2006;7:45-54.
18. Polo SE, Jackson SP. Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications. Genes Dev 2011;25:409-33.
19. Kakarougkas A, Jeggo P. DNA DSB repair pathway choice: an orchestrated handover mechanism. Br J Radiol 2014. [Epub ahead of print].
20. Rothkamm K, Löbrich M. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc Natl Acad Sci U S A 2003;100:5057-62.
21. Martin LM, Marples B, Coffey M, et al. DNA mismatch repair and the DNA damage response to ionizing radiation: making sense of apparently conflicting data. Cancer Treat Rev 2010;36:518-27.
22. Tamulevicius P, Wang M, Iliakis G. Homology-directed repair is required for the development of radioresistance during S phase: interplay between double-strand break repair and checkpoint response. Radiat Res 2007;167:1-11.
23. Escribano-Díaz C, Orthwein A, Fradet-Turcotte A, et al. A cell cycle-dependent regulatory circuit composed of 53BP1-RIF1 and BRCA1-CtIP controls DNA repair pathway choice. Mol Cell 2013;49:872-83.
24. West CM, Barnett GC. Genetics and genomics of radiotherapy toxicity: towards prediction. Genome Med 2011;3:52.
25. Lavin MF. ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks. Oncogene 2007;26:7749-58.
26. Fokas E, Prevo R, Hammond EM, et al. Targeting ATR in DNA damage response and cancer therapeutics Cancer Treat Rev 2014;40:109-17.
27. Lee JH, Paull TT. Activation and regulation of ATM kinase activity in response to DNA double-strand breaks. Oncogene 2007;26:7741-8.
28. Cowell IG, Sunter NJ, Singh PB, et al. gammaH2AX foci form preferentially in euchromatin after ionising-radiation. PLoS One 2007;2:e1057.
29. Van Oorschot B, Oei AL, Nuijens AC, et al. Decay of y-H2AX foci correlates with potentially lethal damage repair and P53 status in human colorectal carcinoma cells. Cell Mol Biol Lett 2013. [Epub ahead of print].
30. Schultz LB, Chehab NH, Malikzay A, et al. p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. J Cell Biol 2000;151:1381-90.
31. Gupta A, Hunt CR, Chakraborty S, et al. Role of 53BP1 in the regulation of DNA double-strand break repair pathway choice. Radiat Res 2014;181:1-8.
32. Surova O, Zhivotovsky B. Various modes of cell death induced by DNA damage. Oncogene 2013;32:3789-97.
33. Gudmundsdottir K, Ashworth A. The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability. Oncogene 2006;25:5864-74.
34. Esashi F, Christ N, Gannon J, et al. CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair. Nature 2005;434:598-604.
35. Yiannakopoulou E. Etiology of familial breast cancer with undetected BRCA1 and BRCA2 mutations: clinical implications. Cell Oncol (Dordr) 2014;37:1-8.
36. Pothuri B. BRCA1- and BRCA2-related mutations: therapeutic implications in ovarian cancer. Ann Oncol 2013;24 Suppl 8:viii22-viii27.
37. Karami F, Mehdipour P. A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer. Biomed Res Int 2013;2013:928562.
38. Kadouri L, Sagi M, Goldberg Y, et al. Genetic predisposition to radiation induced sarcoma: possible role for BRCA and p53 mutations. Breast Cancer Res Treat 2013;140:207-11.
39. Eriksson D, Stigbrand T. Radiation-induced cell death mechanisms. Tumour Biol 2010;31:363-72.
40. Stewart RD, Yu VK, Georgakilas AG, et al. Effects of radiation quality and oxygen on clustered DNA lesions and cell death. Radiat Res 2011;176:587-602.
41. Fuchs Y, Steller H. Programmed cell death in animal development and disease. Cell 2011;147:742-58.
42. Sinha K, Das J, Pal PB, et al. Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis. Arch Toxicol 2013;87:1157-80.
43. Riedl SJ, Salvesen GS. The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol 2007;8:405-13.
44. Ogura A, Oowada S, Kon Y, et al. Redox regulation in radiation-induced cytochrome c release from mitochondria of human lung carcinoma A549 cells. Cancer Lett 2009;277:64-71.
45. Kuribayashi K, Finnberg N, Jeffers JR, et al. The relative contribution of pro-apoptotic p53-target genes in the triggering of apoptosis following DNA damage in vitro and in vivo. Cell Cycle 2011;10:2380-9.
46. Panganiban RA, Snow AL, Day RM. Mechanisms of radiation toxicity in transformed and non-transformed cells. Int J Mol Sci 2013;14:15931-58.
47. Pant V, Xiong S, Jackson JG, et al. The p53-Mdm2 feedback loop protects against DNA damage by inhibiting p53 activity but is dispensable for p53 stability, development, and longevity. Genes Dev 2013;27:1857-67.
48. Chipuk JE, Bouchier-Hayes L, Kuwana T, et al. PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 2005;309:1732-5.
49. Golden EB, Pellicciotta I, Demaria S, et al. The convergence of radiation and immunogenic cell death signaling pathways. Front Oncol 2012;2:88.
50. Cuddihy AR, Bristow RG. The p53 protein family and radiation sensitivity: Yes or no? Cancer Metastasis Rev 2004;23:237-57.
51. Rödel F, Hoffmann J, Distel L, et al. Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. Cancer Res 2005;65:4881-7.
52. Grdina DJ, Murley JS, Miller RC, et al. A survivin-associated adaptive response in radiation therapy. Cancer Res 2013;73:4418-28.
53. Vaseva AV, Moll UM. The mitochondrial p53 pathway. Biochim Biophys Acta 2009;1787:414-20.
54. Zhu HB, Yang K, Xie YQ, et al. Silencing of mutant p53 by siRNA induces cell cycle arrest and apoptosis in human bladder cancer cells. World J Surg Oncol 2013;11:22.
55. Han Y, Wang Y, Xu HT, et al. X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression. Int J Radiat Oncol Biol Phys 2009;75:518-26.
56. Kolesnick R, Fuks Z. Radiation and ceramide-induced apoptosis. Oncogene 2003;22:5897-906.
57. Hotchkiss RS, Strasser A, McDunn JE, et al. Cell death. N Engl J Med 2009;361:1570-83.
58. Jella KK, Garcia A, McClean B, et al. Cell death pathways in directly irradiated cells and cells exposed to medium from irradiated cells. Int J Radiat Biol 2013;89:182-90.
59. Galluzzi L, Kroemer G. Necroptosis: a specialized pathway of programmed necrosis. Cell 2008;135:1161-3.
60. Nehs MA, Lin CI, Kozono DE, et al. Necroptosis is a novel mechanism of radiation-induced cell death in anaplastic thyroid and adrenocortical cancers. Surgery 2011;150:1032-9.
61. Vanden Berghe T, van Loo G, Saelens X, et al. Differential signaling to apoptotic and necrotic cell death by Fas-associated death domain protein FADD. J Biol Chem 2004;279:7925-33.
62. Degterev A, Hitomi J, Germscheid M, et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 2008;4:313-21.
63. Mullins ME, Barest GD, Schaefer PW, et al. Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis. AJNR Am J Neuroradiol 2005;26:1967-72.
64. Campisi J. Aging, cellular senescence, and cancer. Annu Rev Physiol 2013;75:685-705.
65. Muller M. Cellular senescence: molecular mechanisms, in vivo significance, and redox considerations. Antioxid Redox Signal 2009;11:59-98.
66. Tchkonia T, Zhu Y, van Deursen J, et al. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest 2013;123:966-72.
67. Tominaga K, Pereira-Smith OM. The role of chromatin reorganization in the process of cellular senescence. Curr Drug Targets 2012;13:1593-602.
68. Xiao M, Inal CE, Parekh VI, et al. 5-Androstenediol promotes survival of gamma-irradiated human hematopoietic progenitors through induction of nuclear factor-kappaB activation and granulocyte colony-stimulating factor expression. Mol Pharmacol 2007;72:370-9.
69. Mendonca MS, Chin-Sinex H, Dhaemers R, et al. Differential mechanisms of x-ray-induced cell death in human endothelial progenitor cells isolated from cord blood and adults. Radiat Res 2011;176:208-16.
70. Lindsay KJ, Coates PJ, Lorimore SA, et al. The genetic basis of tissue responses to ionizing radiation. Br J Radiol 2007;80:S2-6.
71. Dodson M, Darley-Usmar V, Zhang J. Cellular metabolic and autophagic pathways: traffic control by redox signaling. Free Radic Biol Med 2013;63:207-21.
72. Denton D, Nicolson S, Kumar S. Cell death by autophagy: facts and apparent artefacts. Cell Death Differ 2012;19:87-95.
73. Viganò A, Vasso M, Caretti A, et al. Protein modulation in mouse heart under acute and chronic hypoxia. Proteomics 2011;11:4202-17.
74. Chen N, Karantza-Wadsworth V. Role and regulation of autophagy in cancer. Biochim Biophys Acta 2009;1793:1516-23.
75. Wu WK, Coffelt SB, Cho CH, et al. The autophagic paradox in cancer therapy. Oncogene 2012;31:939-53.
76. Rodriguez-Rocha H, Garcia-Garcia A, Panayiotidis MI, et al. DNA damage and autophagy. Mutat Res 2011;711:158-66.
77. Palumbo S, Comincini S. Autophagy and ionizing radiation in tumors: the "survive or not survive" dilemma. J Cell Physiol 2013;228:1-8.
78. Yi H, Liang B, Jia J, et al. Differential roles of miR-199a-5p in radiation-induced autophagy in breast cancer cells. FEBS Lett 2013;587:436-43.
79. Chiu HW, Fang WH, Chen YL, et al. Monascuspiloin enhances the radiation sensitivity of human prostate cancer cells by stimulating endoplasmic reticulum stress and inducing autophagy. PLoS One 2012;7:e40462.
80. Yu L, Tumati V, Tseng SF, et al. DAB2IP regulates autophagy in prostate cancer in response to combined treatment of radiation and a DNA-PKcs inhibitor. Neoplasia 2012;14:1203-12.
81. Kim KW, Speirs CK, Jung DK, et al. The zinc ionophore PCI-5002 radiosensitizes non-small cell lung cancer cells by enhancing autophagic cell death. J Thorac Oncol 2011;6:1542-52.
82. Pang XL, He G, Liu YB, et al. Endoplasmic reticulum stress sensitizes human esophageal cancer cell to radiation. World J Gastroenterol 2013;19:1736-48.
83. Zhuang W, Qin Z, Liang Z. The role of autophagy in sensitizing malignant glioma cells to radiation therapy. Acta Biochim Biophys Sin (Shanghai) 2009;41:341-51.
84. Chang SH, Minai-Tehrani A, Shin JY, et al. Beclin1-induced autophagy abrogates radioresistance of lung cancer cells by suppressing osteopontin. J Radiat Res 2012;53:422-32.
85. Kim H, Bernard ME, Flickinger J, et al. The autophagy-inducing drug carbamazepine is a radiation protector and mitigator. Int J Radiat Biol 2011;87:1052-60.
86. Chaachouay H, Ohneseit P, Toulany M, et al. Autophagy contributes to resistance of tumor cells to ionizing radiation. Radiother Oncol 2011;99:287-92.
87. Kuwahara Y, Oikawa T, Ochiai Y, et al. Enhancement of autophagy is a potential modality for tumors refractory to radiotherapy. Cell Death Dis 2011;2:e177.
88. Gewirtz DA. Autophagy and senescence in cancer therapy. J Cell Physiol 2014;229:6-9.
89. Huang Q, Shen HM. To die or to live: the dual role of poly(ADP-ribose) polymerase-1 in autophagy and necrosis under oxidative stress and DNA damage. Autophagy 2010;6:1232.
90. Li Y, Zhang J, Chen X, et al. Molecular machinery of autophagy and its implication in cancer. Am J Med Sci 2012;343:155-61.
91. Castedo M, Perfettini JL, Roumier T, et al. Cell death by mitotic catastrophe: a molecular definition. Oncogene 2004;23:2825-37.
92. Mansilla S, Priebe W, Portugal J. Mitotic catastrophe results in cell death by caspase-dependent and caspase-independent mechanisms. Cell Cycle 2006;5:53-60.
93. Vakifahmetoglu H, Olsson M, Zhivotovsky B. Death through a tragedy: mitotic catastrophe. Cell Death Differ 2008;15:1153-62.
94. Vitale I, Galluzzi L, Castedo M, et al. Mitotic catastrophe: a mechanism for avoiding genomic instability. Nat Rev Mol Cell Biol 2011;12:385-92.
95. Ianzini F, Bertoldo A, Kosmacek EA, et al. Lack of p53 function promotes radiation-induced mitotic catastrophe in mouse embryonic fibroblast cells. Cancer Cell Int 2006;6:11.
96. Vogel C, Hager C, Bastians H. Mechanisms of mitotic cell death induced by chemotherapy-mediated G2 checkpoint abrogation. Cancer Res 2007;67:339-45.
97. Luce A, Courtin A, Levalois C, et al. Death receptor pathways mediate targeted and non-targeted effects of ionizing radiations in breast cancer cells. Carcinogenesis 2009;30:432-9.
98. Jaenisch R, Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 2008;132:567-82.
99. Surani MA, Hayashi K, Hajkova P. Genetic and epigenetic regulators of pluripotency. Cell 2007;128:747-62.
100. Kouzarides T. Chromatin modifications and their function. Cell 2007;128:693-705.
101. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007;128:683-92.
102. Pogribny I, Raiche J, Slovack M, et al. Dose-dependence, sex- and tissue-specificity, and persistence of radiation-induced genomic DNA methylation changes. Biochem Biophys Res Commun 2004;320:1253-61.
103. Raiche J, Rodriguez-Juarez R, Pogribny I, et al. Sex- and tissue-specific expression of maintenance and de novo DNA methyltransferases upon low dose X-irradiation in mice. Biochem Biophys Res Commun 2004;325:39-47.
104. Antwih DA, Gabbara KM, Lancaster WD, et al. Radiation-induced epigenetic DNA methylation modification of radiation-response pathways. Epigenetics 2013;8:839-48.
105. Kuhmann C, Weichenhan D, Rehli M, et al. DNA methylation changes in cells regrowing after fractioned ionizing radiation. Radiother Oncol 2011;101:116-21.
106. Chaudhry MA, Omaruddin RA. Differential DNA methylation alterations in radiation-sensitive and -resistant cells. DNA Cell Biol 2012;31:908-16.
107. Hofstetter B, Niemierko A, Forrer C, et al. Impact of genomic methylation on radiation sensitivity of colorectal carcinoma. Int J Radiat Oncol Biol Phys 2010;76:1512-9.
108. Cho HJ, Kim SY, Kim KH, et al. The combination effect of sodium butyrate and 5-Aza-2'-deoxycytidine on radiosensitivity in RKO colorectal cancer and MCF-7 breast cancer cell lines. World J Surg Oncol 2009;7:49.
109. Karagiannis TC, El-Osta A. Clinical potential of histone deacetylase inhibitors as stand alone therapeutics and in combination with other chemotherapeutics or radiotherapy for cancer. Epigenetics 2006;1:121-6.
110. Camphausen K, Tofilon PJ. Inhibition of histone deacetylation: a strategy for tumor radiosensitization. J Clin Oncol 2007;25:4051-6.
111. Morgan WF, Sowa MB. Effects of ionizing radiation in non irradiated cells. Proc Natl Acad Sci USA 2005;102:14127-8.
112. Morgan WF, Sowa MB. Non-targeted bystander effects induced by ionizing radiation. Mutat Res 2007;616:159-64.
113. Han W, Chen S, Yu KN, et al. Nitric oxide mediated DNA double strand breaks induced in proliferating bystander cells after alpha-particle irradiation. Mutat Res 2010;684:81-9.
114. Sedelnikova OA, Nakamura A, Kovalchuk O, et al. DNA double-strand breaks form in bystander cells after microbeam irradiation of three-dimensional human tissue models. Cancer Res 2007;67:4295-302.
115. Kim JG, Moon-Taek P, Heo K, et al. Epigenetics meets radiation biology as a new approach in cancer treatment. Int J Mol Sci 2013;14:15059-73.
116. Kovalchuk O, Baulch JE. Epigenetic changes and nontargeted radiation effects-is there a link? Environ Mol Mutagen 2008;49:16-25.
117. Baskar R, Balajee AS, Geard CR. Effects of low and high let radiations on bystander human lung fibroblast cell survival. Int J Radiat Biol 2007;83:551-9.
118. Little JB. Cellular radiation effects and the bystander response. Mutat Res 2006;597:113-8.
119. Xu QY, Gao Y, Liu Y, et al. Identification of differential gene expression profiles of radioresistant lung cancer cell line established by fractionated ionizing radiation in vitro. Chin Med J (Engl) 2008;121:1830-7.
120. Snyder AR, Morgan WF. Gene expression profiling after irradiation: clues to understanding acute and persistent responses? Cancer Metastasis Rev 2004;23:259-68.
121. Dent P, Yacoub A, Fisher PB, et al. MAPK pathways in radiation responses. Oncogene 2003;22:5885-96.
122. McBride WH, Iwamoto KS, Syljuasen R, et al. The role of the ubiquitin/proteasome system in cellular responses to radiation. Oncogene 2003;22:5755-73.
123. Chen X, Shen B, Xia L, et al. Activation of nuclear factor kappaB in radioresistance of TP53-inactive human keratinocytes. Cancer Res 2002;62:1213-21.
124. Kajanne R, Miettinen P, Tenhunen M, et al. Transcription factor AP-1 promotes growth and radioresistance in prostate cancer cells. Int J Oncol 2009;35:1175-82.
125. Affolter A, Fruth K, Brochhausen C, et al. Activation of mitogen-activated protein kinase extracellular signal-related kinase in head and neck squamous cell carcinomas after irradiation as part of a rescue mechanism. Head Neck 2011;33:1448-57.
126. Zingg D, Riesterer O, Fabbro D, et al. Differential activation of the phosphatidylinositol 3-kinase/Akt survival pathway by ionizing radiation in tumor and primary endothelial cells. Cancer Res 2004;64:5398-406.
127. Narang H, Krishna M. Mitogen-activated protein kinases: specificity of response to dose of ionizing radiation in liver. J Radiat Res 2004;45:213-20.
128. Brieger J, Schroeder P, Gosepath J, et al. Vascular endothelial growth factor and basic fibroblast growth factor are released by squamous cell carcinoma cell lines after irradiation and increase resistance to subsequent irradiation. Int J Mol Med 2005;16:159-64.
129. Tsai MH, Cook JA, Chandramouli GV, et al. Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation. Cancer Res 2007;67:3845-52.
130. Amundson SA, Do KT, Shahab S, et al. Identification of potential mRNA biomarkers in peripheral blood lymphocytes for human exposure to ionizing radiation. Radiat Res 2000;154:342-6.
131. Amundson SA, Bittner M, Chen Y, et al. Fluorescent cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress responses. Oncogene 1999;18:3666-72.
132. Jen KY, Cheung VG. Transcriptional response of lymphoblastoid cells to ionizing radiation. Genome Res 2003;13:2092-100.
133. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001;98:5116-21.
134. Stassen T, Port M, Nuyken I, et al. Radiation-induced gene expression in MCF-7 cells. Int J Radiat Biol 2003;79:319-31.
135. Heinloth AN, Shackelford RE, Innes CL, et al. ATM-dependent and -independent gene expression changes in response to oxidative stress, gamma irradiation, and UV irradiation. Radiat Res 2003;160:273-90.
136. Li Z, Xia L, Lee LM, et al. Effector genes altered in MCF-7 human breast cancer cells after exposure to fractionated ionizing radiation. Radiat Res 2001;155:543-53.
137. Marko NF, Dieffenbach PB, Yan G, et al. Does metabolic radiolabeling stimulate the stress response? Gene expression profiling reveals differential cellular responses to internal beta vs. external gamma radiation. Faseb J 2003;17:1470-86.
138. Heinloth AN, Shackelford RE, Innes CL, et al. Identification of distinct and common gene expression changes after oxidative stress and gamma and ultraviolet radiation. Mol Carcinog 2003;37:65-82.
139. Balcer-Kubiczek EK, Zhang XF, Harrison GH, et al. Delayed expression of hpS2 and prolonged expression of CIP1/ WAF1/SDI1 in human tumor cells irradiated with X-rays, fission neutrons or 1 GeV/nucleon Fe ions. Int J Radiat Biol 1999;75:529-41.
140. Robles AI, Bemmels NA, Foraker AB, et al. APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis. Cancer Res 2001;61:6660-4.
141. Park WY, Hwang CI, Im CN, et al. Identification of radiation-specific responses from gene expression profile. Oncogene 2002;21:8521-8.
142. Chaudhry MA, Chodosh LA, McKenna WG, et al. Gene expression profile of human cells irradiated in G1 and G2 phases of cell cycle. Cancer Lett 2003;195:221-33.
143. Bravatà V, Cammarata FP, Forte GI, et al. "Omics" of HER2-positive breast cancer. OMICS 2013;17:119-29.
144. Bravatà V, Stefano A, Cammarata FP, et al. Genotyping analysis and 18FDG uptake in breast cancer patients: a preliminary research. J Exp Clin Cancer Res 2013;32:23.
145. Minafra L, Norata R, Bravatà V, et al. Unmasking epithelial-mesenchymal transition in a breast cancer primary culture: a study report. BMC Res Notes 2012;5:343.